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Genetically Modi®ed Fibroblasts Help Dissecting Molecular Mechanisms of Keratinocyte Growth
and Differentiation
Formation and maintenance of the mature epidermis rely on a tight
balance of keratinocyte proliferation and terminal differentiation.
This, in turn, is regulated by a cytokine network between
keratinocytes and dermal ®broblasts. For a study of such
epithelial±mesenchymal interactions and their regulation, organo-
typic cocultures of the two cell types are useful in vitro models.
Keratinocytes and ®broblasts generate a normal epidermis irrespec-
tive of the species and the tissue origin of ®broblasts. Therefore, the
combination of mouse ®broblasts and human keratinocytes has
been used to identify the origin of molecules involved in epidermal
tissue reconstitution and growth regulation. Moreover, mouse
®broblasts derived from transgenic animals, even from embryonic
lethal phenotypes, can be employed in this model to assess their
effects on keratinocyte functions. In this issue, Maas-Szabowski and
Szabowski et al (p. 814) communicate results of such studies. They
used mouse ®broblasts defective in the AP-1 constituents c-Jun and
JunB to reveal the antagonistic effects of these factors on human
keratinocyte growth and differentiation. They also identi®ed the
hematopoietic growth factor granulocyte macrophage-colony
stimulating factor as a novel regulator. In fact, both granulocyte
macrophage-colony stimulating factor and keratinocyte growth
factor were found to be major mediators of ®broblast±keratinocyte
interactions. The expression of both factors is induced by IL-1
released by epithelial cells. Several genes are known to be regulated
by IL-1 via members of the transcription factor family AP-1,
namely c-Jun and JunB, thus explaining the effects disclosed by use
of c-Jun and JunB de®cient cells. These studies indicate that the
heterologous cocultures with genetically modi®ed mouse ®bro-
blasts provide a versatile tool for dissecting molecular pathways
involved in epithelial±mesenchymal interactions. The assay system
may be similarly useful for elucidation of novel drug targets, for the
dissection of disease mechanisms, or for the design of novel
therapeutic strategies for skin diseases or disturbances of epithelial±
mesenchymal interactions in general.
Relation of Skin Polyamines to the Hairless Phenotype in Transgenic Mice
Lack of hair is not an uncommon feature among different mouse
strains. A hairless phenotype can result from a single gene mutation,
e.g., in the hairless gene that encodes a putative zinc-®nger
transcription factor expressed in the hair follicle, the epidermis, and
the brain. In this issue, PietilaÈ et al (p. 799) report a different,
intriguing, cause for hairlessness in transgenic mice. They generated
a mouse line with activated polyamine catabolism due to
overexpression of spermidine/spermine N1-acetyltransferase.
Phenotypic changes in these animals included permanent loss of
hair at the age of 3 wk. The ®rst hair cycle appeared to be
completed normally, but at postnatal day 15, although macro-
scopically indistinguishable from their syngenic littermates, the
transgenic animals already showed microscopic signs of hair follicle
degeneration. Wild-type mice started their second anagen phase at
day 27, whereas the transgenic animals did not display functional
hair follicles at that time. Instead, the follicles were replaced by
dermal cysts and epidermal utriculi. Interestingly, an identical
hairless phenotype in terms of the onset of hair loss and histologic
changes has been described for transgenic mice overexpressing
ornithine decarboxylase under the control of a keratin promoter.
Both transgenic lines share a common feature, a massive over-
accumulation of putrescine in the skin, and the hypothesis is that
excessive accumulation of putrescine contributes to the observed
abnormalities in the hair cycle. This assumption was strengthened
by the ®nding that doubly transgenic mice overexpressing both
spermidine/spermine N1-acetyl-transferase and ornithine decar-
boxylase, and with extremely high levels of putrescine in the skin,
exhibited clearly more severe skin changes than singly transgenic
animals. It has also been suggested that an activation of polyamine
biosynthesis is a necessary component of skin tumorigenesis.
However, in this study, the spermidine/spermine N1-acetyltrans-
ferase transgenic mice were signi®cantly more resistant to the
development of papillomas in a two-stage skin carcinogenesis assay,
a somewhat unexpected ®nding that still requires further study. So
far, the results suggest that putrescine plays a pivotal role in
induction of a normal hair cycle, possibly via interference of the
DNA-binding activity of zinc-®nger proteins, such as the hairless
gene product.
Fibrillin-1 as a Reporter for Photoaging Repair
Photoaging is a common problem in clinical dermatology today.
Photoaged skin appears coarse and roughened, is deeply wrinkled,
and exhibits a marked reduction in its ability to recoil; however, the
mechanisms of formation of coarse and ®ne wrinkles are only
understood in part. Changes within the matrix of the dermis and at
the dermal±epidermal junction, such as marked reductions in
procollagens and the ®brillin-rich micro®brillar apparatus in this
area, seem to contibute to wrinkle formation. Topically applied all-
trans retinoic acid can repair photoaged dermal matrix, but this
takes at least 6 mo of treatment. In this issue, Watson et al (p. 662)
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describe a faster way to assess the potential for repair of photoaged
skin by pharmaceutical agents, a 4 d patch protocol applied to
photodamaged skin. They used retinoic acid as an exemplar repair
agent in the protocol and showed that ®brillin-1 is a useful marker
of therapeutic effectiveness. They also examined the abundance and
distribution of ®brillin-1 prior to, and following, a long, 192 wk,
all-trans retinoic acid treatment of severely photoaged forearm and
facial skin. Biopsies were evaluated with transmission electron
microscopy, immunohistochemistry, and in situ hybridization
immunohistochemistry. Electron microscopy revealed aberrant
elastic ®bers in the papillary dermis of photoaged forearm skin,
with sparse micro®brillar apparatus and interstitial collagen. After
application of all-trans retinoic acid, there was increased deposition
of these dermal matrix components, with the aberrant elastic ®bers
no longer apparent. Signi®cant increases were observed at the
protein and mRNA levels for ®brillin-1 following all-trans retinoic
acid treatments. The authors showed that topical treatment
positively affected ®brillin-1 production by both keratinocytes
and dermal ®broblasts. Thus, the study suggests that all-trans
retinoic acid can target ®brillin-1 production in photoaged skin,
and that this protein can be used as a ``reporter'' molecule in
protocols for testing the utility of topical agents in the repair of
photoaged skin.
632 IN THIS ISSUE THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
